Related Experiment Video
Updated: Dec 13, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Predictors of Coronavirus Disease 2019 Severity: A Retrospective Study of 64 Cases
Huihuang Huang1, Bing Song1, Zhe Xu1
1Treatment and Research Center for Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, China.
Insights
This study identified age and serum ferritin as key predictors of coronavirus disease 2019 (COVID-19) severity. Monitoring ferritin and inflammatory markers can help predict disease progression and treatment effectiveness in COVID-19 patients.
Area of Science:
- Infectious Diseases
- Clinical Medicine
- Biochemistry
Background:
- Coronavirus disease 2019 (COVID-19) poses a significant global health challenge.
- Understanding predictors of COVID-19 severity is crucial for effective patient management.
- Clinical characteristics and biomarkers require further investigation for prognostic value.
Purpose of the Study:
- To analyze clinical features of COVID-19 patients.
- To identify potential predictors of COVID-19 disease severity.
- To evaluate the association of clinical factors and biomarkers with COVID-19 outcomes.
Main Methods:
- Retrospective analysis of clinical data from 64 COVID-19 patients.
- Comparison of clinical characteristics between severe and non-severe cases.
- Statistical analysis to determine associations between variables and disease severity.
Main Results:
- Age and elevated serum ferritin levels were significantly associated with increased COVID-19 severity.
- No significant difference in illness duration or respiratory support days between methylprednisolone dose groups.
- Higher mean hospital stay observed in the high-dose methylprednisolone group.
Conclusions:
- Age and serum ferritin are important predictors of COVID-19 severity.
- Monitoring ferritin, IL-6, CRP, LDH, and ESR may aid in predicting severity and treatment response.
- Methylprednisolone dosage may influence hospital stay duration.
Abstract:
This study aimed to analyze the clinical characteristics and potential predictors of disease severity in patients with coronavirus disease 2019 (COVID-19). We retrospectively analyzed the clinical data from 64 (37 male and 27 female) patients with COVID-19. Their mean age was 47.8 years; 43 (67.2%) cases were non-severe, 21 (32.8%) were severe, and 2 patients (3.1%) died. Age and serum ferritin levels were significantly associated with COVID-19 severity. There were no significant differences in the duration of severe illness or the number of days on high-level respiratory support between the low-dose and high-dose methylprednisolone groups. The mean number of days in hospital in the high-dose group was higher than that in the low-dose group. Repeated monitoring of ferritin, interleukin-6, C-reactive protein, lactic acid dehydrogenase, and erythrocyte sedimentation rate during COVID-19 treatment may assist in the prediction of disease severity and evaluation of treatment effects.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Single Nucleotide Polymorphisms-SNPs
Steps in Outbreak Investigation
Residuals and Least-Squares Property
If the observed data point lies above the line, the residual is positive, and the line underestimates the actual data value for y. If the observed data point lies below the line, the residual is negative, and the line overestimates the actual data value for y.
The process of fitting the best-fit...
